Investigating the International Normalized Ratio Thresholds for Complication in Shoulder Arthroplasty.
Journal
The Journal of the American Academy of Orthopaedic Surgeons
ISSN: 1940-5480
Titre abrégé: J Am Acad Orthop Surg
Pays: United States
ID NLM: 9417468
Informations de publication
Date de publication:
01 Feb 2021
01 Feb 2021
Historique:
received:
27
03
2020
accepted:
21
05
2020
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
29
7
2021
Statut:
ppublish
Résumé
In patients on warfarin anticoagulation therapy, elective shoulder arthroplasty surgeons must carefully balance bleeding and embolic risks. Currently, an international normalized ratio (INR) threshold of 1.5 is supported in the setting of elective surgery. However, no previous study has investigated the optimal preoperative INR target specifically in shoulder arthroplasty. The purpose of this study was to evaluate the association of preoperative INR with rates of transfusion, complication, and readmission/revision surgery in shoulder arthroplasty. Patients who underwent elective shoulder arthroplasty were identified in a national database. The primary outcome of interest was the risk for all-cause complication at 30 days postoperatively. Major and minor complication, revision surgery, and readmission rates were also investigated. From 2006 to 2016, 1,014 procedures were identified who had undergone elective shoulder arthroplasty with a perioperative INR lab result within 24 hours of surgery. In our cohort, 550 patients (54.2%) were women, with an average age of 71.0 ± 9.8 years. After controlling for confounders, patients with a preoperative INR > 1.5 were 18.9 times as likely to have a major complication as those with a preoperative INR ≤ 1.0 (P = 0.003). Patients with an INR of 1.25 < INR ≤ 1.5 did not have a statistically significant risk of minor or major complication in comparison with those with an INR ≤ 1.0 (P = 0.23, P = 0.67). Although recent hip and knee arthroplasty literature has found that an INR < 1.25 may be an optimal preoperative INR goal, our results did not find an increased risk for bleeding and complication with an INR ≤ 1.5 for shoulder arthroplasty. These results support current guidelines recommending a preoperative INR ≤ 1.5 for shoulder arthroplasty.
Sections du résumé
BACKGROUND
BACKGROUND
In patients on warfarin anticoagulation therapy, elective shoulder arthroplasty surgeons must carefully balance bleeding and embolic risks. Currently, an international normalized ratio (INR) threshold of 1.5 is supported in the setting of elective surgery. However, no previous study has investigated the optimal preoperative INR target specifically in shoulder arthroplasty. The purpose of this study was to evaluate the association of preoperative INR with rates of transfusion, complication, and readmission/revision surgery in shoulder arthroplasty.
METHODS
METHODS
Patients who underwent elective shoulder arthroplasty were identified in a national database. The primary outcome of interest was the risk for all-cause complication at 30 days postoperatively. Major and minor complication, revision surgery, and readmission rates were also investigated.
RESULTS
RESULTS
From 2006 to 2016, 1,014 procedures were identified who had undergone elective shoulder arthroplasty with a perioperative INR lab result within 24 hours of surgery. In our cohort, 550 patients (54.2%) were women, with an average age of 71.0 ± 9.8 years. After controlling for confounders, patients with a preoperative INR > 1.5 were 18.9 times as likely to have a major complication as those with a preoperative INR ≤ 1.0 (P = 0.003). Patients with an INR of 1.25 < INR ≤ 1.5 did not have a statistically significant risk of minor or major complication in comparison with those with an INR ≤ 1.0 (P = 0.23, P = 0.67).
DISCUSSION
CONCLUSIONS
Although recent hip and knee arthroplasty literature has found that an INR < 1.25 may be an optimal preoperative INR goal, our results did not find an increased risk for bleeding and complication with an INR ≤ 1.5 for shoulder arthroplasty. These results support current guidelines recommending a preoperative INR ≤ 1.5 for shoulder arthroplasty.
Identifiants
pubmed: 33492016
doi: 10.5435/JAAOS-D-20-00280
pii: 00124635-202102010-00009
doi:
Substances chimiques
Warfarin
5Q7ZVV76EI
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
131-137Informations de copyright
Copyright © 2020 by the American Academy of Orthopaedic Surgeons.
Références
Kim SH, Wise BL, Zhang Y, Szabo RM: Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am 2011;93:2249-2254.
Oppermann J, Celik E, Bredow J, et al.: Shoulder arthroplasty in Germany: 2005-2012. Arch Orthop Trauma Surg 2016;136:723-729.
Villacis D, Sivasundaram L, Pannell WC, Heckmann N, Omid R, Hatch GF III: Complication rate and implant survival for reverse shoulder arthroplasty versus total shoulder arthroplasty: Results during the initial 2 years. J Shoulder Elbow Surg 2016;25:927-935.
Jacobs JJ, Mont MA, Bozic KJ, et al.: American Academy of Orthopaedic Surgeons clinical practice guideline on: Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am 2012;94:746-747.
Douketis JD, Berger PB, Dunn AS, et al.: The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:299s-339s.
Jaffer AK, Brotman DJ, Chukwumerije N: When patients on warfarin need surgery. Cleve Clin J Med 2003;70:973-984.
Vitale MA, Vanbeek C, Spivack JH, Cheng B, Geller JA: Pharmacologic reversal of warfarin-associated coagulopathy in geriatric patients with hip fractures: A retrospective study of thromboembolic events, postoperative complications, and time to surgery. Geriatr Orthop Surg Rehabil 2011;2:128-134.
Parvizi J, Ceylan HH, Kucukdurmaz F, Merli G, Tuncay I, Beverland D: Venous thromboembolism following hip and knee arthroplasty: The role of aspirin. J Bone Joint Surg Am 2017;99:961-972.
Sachs RA, Smith JH, Kuney M, Paxton L: Does anticoagulation do more harm than good?: A comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthroplasty. J Arthroplasty 2003;18:389-395.
Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH: Does “excessive” anticoagulation predispose to periprosthetic infection? J Arthroplasty 2007;22:24-28.
Benarroch-Gampel J, Sheffield KM, Duncan CB, et al.: Preoperative laboratory testing in patients undergoing elective, low-risk ambulatory surgery. Ann Surg 2012;256:518-528.
Donato DP, Kwok AC, Bishop MO, Presson AP, Agarwal JP: Unplanned readmission in outpatient hand surgery: An analysis of 23,613 patients in the NSQIP data set. Eplasty 2017;17:e36.
Blasdale C, Lawrence CM: Perioperative International Normalized Ratio level is a poor predictor of postoperative bleeding complications in dermatological surgery patients taking warfarin. Br J Dermatol 2008;158:522-526.
Tamim H, Habbal M, Saliba A, et al.: Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study. J Thromb Thrombolysis 2016;41:301-311.
Torn M, Rosendaal FR: Oral anticoagulation in surgical procedures: Risks and recommendations. Br J Haematol 2003;123:676-682.
Rudasill SE, Liu J, Kamath AF: Revisiting the International Normalized Ratio (INR) threshold for complications in primary total knee arthroplasty: An analysis of 21,239 cases. J Bone Joint Surg Am 2019;101:514-522.
Sivasundaram LM, Pannell W, Heckmann N, Alluri RK, Omid R, Hatch GF: Database studies: An increasing trend in the United States orthopaedic literature. Curr Orthop Pract 2016;27:673-679.
Bohl DD, Russo GS, Basques BA, et al.: Variations in data collection methods between national databases affect study results: A comparison of the nationwide inpatient sample and National Surgical Quality Improvement Program databases for lumbar spine fusion procedures. J Bone Joint Surg Am 2014;96:e193.
Bohl DD, Grauer JN, Leopold SS: Editor's spotlight/take 5: Nationwide inpatient sample and National Surgical Quality Improvement Program give different results in hip fracture studies. Clin Orthop Relat Res 2014;472:1667-1671.
Golinvaux NS, Bohl DD, Basques BA, Fu MC, Gardner EC, Grauer JN: Limitations of administrative databases in spine research: A study in obesity. Spine J 2014;14:2923-2928.